Mishra Smruti, Helminiak Luke, Kim Hwan Keun
Center for Infectious Diseases, Stony Brook University, Stony Brook, New York, United States of America.
Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.
PLoS Pathog. 2025 Jun 26;21(6):e1013277. doi: 10.1371/journal.ppat.1013277. eCollection 2025 Jun.
Pathogenic Rickettsia species target vascular endothelial cells and cause systemic vasculitis. As obligate intracellular bacterial pathogens, Rickettsia must secure nutritional resources within the cytoplasm of endothelial cells while simultaneously subverting the innate immune defense system. With advances in rickettsial and host genetics, recent studies have identified novel molecular mechanisms involved in the complex interactions between Rickettsia and endothelial cells. However, it remains unclear how Rickettsia shields pathogen-derived immune stimulants, such as lipopolysaccharides (LPS) and peptidoglycan fragments, from immune recognition during intracellular replication. Prior work described two Rickettsia conorii variants with kkaebi transposon insertions in the polysaccharide synthesis operon (pso). Biochemical and immunological analyses revealed that pso is responsible for the biosynthesis of O-antigen (O-Ag) and the proper assembly of surface proteins. In the present work, we document that pso variant HK2 exhibits reduced capacities to adhere to and invade microvascular endothelial cells. Despite the low intracellular abundance, HK2 induced significantly higher levels of proinflammatory cytokines and chemokines, leading to premature cell death. Notably, HK2 exhibited defective intracellular survival in bone marrow-derived macrophages. This inability to dampen endothelial cell-mediated immune stimulation and resist macrophage-induced bactericidal activities resulted in the rapid elimination of viable Rickettsia in the mouse model of spotted fever. Further, when tested as a live-attenuated vaccine, HK2 elicited robust protective immunity against lethal spotted fever pathogenesis. Our work highlights the crucial role of pso in enabling Rickettsia to evade immune surveillance during intracellular replication within endothelial cells, ultimately delaying pathogen-induced programmed cell death and escaping immune defense mechanisms.
致病性立克次体物种靶向血管内皮细胞并引起系统性血管炎。作为专性细胞内细菌病原体,立克次体必须在内皮细胞胞质内获取营养资源,同时颠覆固有免疫防御系统。随着立克次体和宿主遗传学的进展,最近的研究已经确定了参与立克次体与内皮细胞之间复杂相互作用的新分子机制。然而,目前尚不清楚立克次体如何在细胞内复制过程中保护病原体衍生的免疫刺激物,如脂多糖(LPS)和肽聚糖片段,使其不被免疫识别。先前的研究描述了两种在多糖合成操纵子(pso)中有kk aebi转座子插入的康氏立克次体变体。生化和免疫学分析表明,pso负责O抗原(O-Ag)的生物合成和表面蛋白的正确组装。在本研究中,我们记录到pso变体HK2黏附并侵袭微血管内皮细胞的能力降低。尽管细胞内丰度较低,但HK2诱导的促炎细胞因子和趋化因子水平显著更高,导致细胞过早死亡。值得注意的是,HK2在骨髓来源的巨噬细胞中表现出细胞内存活缺陷。这种无法抑制内皮细胞介导的免疫刺激和抵抗巨噬细胞诱导的杀菌活性的能力,导致在斑点热小鼠模型中快速清除活的立克次体。此外,当作为减毒活疫苗进行测试时,HK2引发了针对致命斑点热发病机制的强大保护性免疫。我们的工作强调了pso在使立克次体在内皮细胞内复制期间逃避免疫监视中的关键作用,最终延迟病原体诱导的程序性细胞死亡并逃避免疫防御机制。